Nanjing Hicin Pharmaceutical is a biotechnology and pharmaceutical company founded in 2003 with a focus on crafting a healthier future through the production of a diverse range of pharmaceuticals. The company's portfolio includes antivirals, antibiotics, endocrine drugs, gastrointestinal medications, and orthopedic treatments in various dosage forms.
Specializing in the production of pharmaceutical products, drugs, and synthetic chemicals, Nanjing Hicin Pharmaceutical is at the forefront of innovation in the healthcare industry. The company's commitment to providing a wide range of pharmaceutical preparations underscores its dedication to meeting diverse medical needs.
With a slogan emphasizing their commitment to a healthier future, Nanjing Hicin Pharmaceutical has positioned itself as a key player in the pharmaceutical and biotechnology sectors. As the company continues to expand its portfolio and reach, it presents an intriguing opportunity for investors seeking to engage with the evolving landscape of healthcare and biotechnology.
There is no investment information
No recent news or press coverage available for 南京海辰药业股份有限公司.